Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™

SAN ANTONIO--(BUSINESS WIRE)--On May 12, 2015, the U.S. Government Accountability Office (GAO) issued a bid protest decision upholding the Department of Veterans Affairs (VA) decision to award a sole-source contract for a mercury-free ultraviolet (UV) room disinfection system for the Clement J. Zablocki Veterans Affairs Medical Center located in Milwaukee, Wisconsin.

In its decision, the GAO noted, “Because the agency’s market research revealed only one source for a mercury-free UV disinfecting lamp, and because there is no dispute about the hazards of mercury gas exposure, we conclude that the agency’s decision to award the contract on a sole-source basis to the only source of a mercury-free product was reasonable.” The VA's market research identified 57 contractors under the relevant GSA schedule contract, but only one capable of providing a mercury-free xenon disinfection lamp, according to the decision. That supplier is Xenex Disinfection Services.

The GAO decision states, “in October 2011, the Milwaukee VA Medical Center, noting the hazards of short- and long-term exposure to mercury vapor (e.g., vomiting, diarrhea, memory loss, tremors), established a policy stating that: ‘All Divisions . . . are hereby encouraged to minimize procurement of Mercury-containing instruments and are advised to seek safer substitutes wherever possible.’”

Xenex manufactures and distributes a pulsed xenon UV disinfection system which utilizes a mercury-free, full-spectrum pulsed xenon UV bulb to quickly destroy the deadly pathogens that cause hospital acquired infections (HAIs). Xenex’s Germ-Zapping Robot™ creates UV-C light that covers the entire germicidal spectrum (200 – 280 nanometers). Xenex robots reduce the bacterial load in hospitals that is often associated with an increased risk for HAIs, including Clostridium difficile (C.diff) and Methicillin-resistant Staphylococcus aureus (MRSA).

In June 2014, Xenex CEO Morris Miller testified about the effectiveness of its germ-zapping robot in reducing infection rates at U.S. hospitals and VA facilities before the U.S. House of Representatives Committee on Science, Space, and Technology; Subcommittee on Research and Technology; and Subcommittee on Oversight in the hearing “Technology for Patient Safety at Veterans Hospitals.” At that time, the Iowa City VA Health Care System reported a 30 percent reduction in C.diff infections and the Jack C. Montgomery VA Medical Center reported a 50 percent decrease in Multi-Drug Resistant Organism (MDRO) infections after the facilities began using Xenex robots for room disinfection.

Numerous hospitals that purchased Xenex robots have reported greater than 50 percent decreases in MRSA and C.diff infections in peer-reviewed literature, documenting how they used the Xenex robot in their real world hospital environment to reduce infection rates. MD Anderson Cancer Center, the Central Texas Veterans Health Care System, Cooley Dickinson (a Mass Gen affiliate) and other hospitals have published 10 studies proving the robot’s efficacy in highly regarded scientific journals including the American Journal of Infection Control (AJIC), Journal of Infection Prevention, Infection Control & Hospital Epidemiology (ICHE) and BMC Infectious Diseases.

“The GAO decision states that Xenex offered the best value to the government because ‘no other companies can meet the specifications required of a non-mercury UV disinfection bulb capable of producing pulses of 200 nm to 280 nm.’ Several U.S. hospitals have published outcome studies showing a decrease in infection rates when they used Xenex robots to disinfect their rooms. There are no peer-reviewed studies indicating that single spectrum mercury bulb UV devices have any impact on infection rates,” said Mike DelVacchio, senior vice president of sales and marketing for Xenex.

A new study published in AJIC and performed at the Central Texas Veterans Health Care System demonstrated that the Xenex robot is as effective even when surfaces haven’t been cleaned prior. In 2014, the Central Texas VA researchers, led by Dr. Chetan Jinadatha, conducted a study to compare the effectiveness of manual disinfection alone to manual disinfection plus pulsed xenon UV disinfection. The study found that manual cleaning plus pulsed xenon UV light disinfection was far more effective at eliminating MRSA bacteria and was 23 percent faster when integrated into the cleaning process.

Xenex germ-zapping robots are now included in infection control protocols in nearly 300 hospitals, including Veterans Affairs and DoD healthcare facilities, skilled nursing facilities, ambulatory surgery centers and long-term acute care facilities throughout the U.S. and Europe. Designed for speed, ease of use and portability, the Xenex device can be operated by a hospital’s environmental services staff without disrupting hospital operations. With a five-minute disinfection cycle, the robot eliminates harmful microorganisms safely and effectively and without introducing mercury into the hospital environment.

The GAO’s decision in its entirety can be found at: http://www.gao.gov/products/B-410988.2#mt=summary

About Xenex Disinfection Services
Xenex's patented pulsed xenon Full Spectrum UV room disinfection system is a pesticidal device used for the advanced cleaning of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The Xenex mission is to eliminate harmful bacteria, viruses and spores that can cause hospital acquired infections in the patient environment, and to become the new standard method for disinfection in healthcare facilities worldwide. The company is backed by well-known investors including Brandon Point/Malin Corporation, Battery Ventures, Targeted Technology Fund II and RK Ventures. For more information, visit www.xenex.com.

Contacts
Xenex Disinfection Services
Melinda Hart, 210-824-3433
melinda.hart@xenex.com

Source: http://www.businesswire.com/news/home/20150519006368/en/GAO-Affirms-VA-Contract-Mercury-Free-UV-Disinfection#.VWRswVLchlk

May 19th 2015 back

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more